 |
| |
DNAvaccine.com mailing list
To get on the DNAvaccine.com mailing list, please email me at peratt@aldevron.com . The mailing list is a good way to find out the latest information about new technology, upcoming conference, or just general information that you may find resourceful for your day to day experiments.
I hope to hear from you soon. |
|
|
Fresh boost to hunt for AIDS vaccine in India
|
|
Posted by administrator on Wednesday, August 27 @ 04:02:41 PDT (8 reads)
Dr Sanjay Mehendale, deputy director (senior grade) at NARI, said the trials were at the planning stage. Approval is being sought from various bodies. Officials of the International AIDS Vaccine Initiative said further research is required after the success of the first phase. They pointed out that the prime boost regimen should be able to help strengthen the modest immune responses observed in the first phase.
Read More...
(Read More... | Score: 0)
|
|
New Strategy for PSA Vaccine
|
|
Posted by administrator on Monday, August 25 @ 07:11:47 PDT (21 reads)
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients.
Read More...
(Read More... | Score: 0)
|
|
New Smallpox Vaccine Being Tested
|
|
Posted by administrator on Monday, August 25 @ 07:09:44 PDT (17 reads)
The current vaccine can have serious side effects. It is made with a different virus than smallpox, but the virus is live. The vaccine causes a blister to form at the vaccination site, which fills with pus and eventually forms a scar. If proper care is not taken, the vaccinia virus can spread to other parts of the body and other people.
The Centers for Disease Control and Prevention estimates that for every 1 million people vaccinated, one or 2 may die and others will have serious side effects.
In the study of the new vaccine, healthy volunteers, those with atopic dermatitis, and those with a history of atopic dermatitis will be vaccinated. Their immune reaction will be measured through blood tests, and side effects will be tracked in a journal.
Read More...
(Read More... | Score: 0)
|
|
Measles Return to Haunt US, Vaccine Fears Adding to the Problem
|
|
Posted by administrator on Monday, August 25 @ 07:08:00 PDT (14 reads)
Viral disease expert Dr. Jane Seward says the developments are indeed a reminder that Americans are still at risk for measles, an easily transmissible airborne virus.
Read More...
(Read More... | Score: 0)
|
|
Lung cancer vaccine shows great promis
|
|
Posted by administrator on Friday, August 22 @ 07:12:20 PDT (27 reads)
Whether Lucanix will prove itself a worthy combatant against the world's most deadly type of cancer won't be known for several years. It must be tested on up to 700 people in a worldwide Phase 3 clinical trial and treated at 90 sites in the United States, Canada, India and Europe.
Read More...
(Read More... | Score: 0)
|
| |
| Friday, August 22 | | · | Vical partners with Karolinska and Swedish agency for HIV vaccine development |
| Friday, August 15 | | · | Phase I prime-boost vaccine trial to be conducted in Chennai, Pune |
| Thursday, August 14 | | · | INO: Expansion of License Agreement w/International AIDS Vaccine Initiative |
| Wednesday, August 13 | | · | Vaccine/Gene Therapy Combo for Brain Cancer in Dog |
| · | Gardasil side effects prompt CDC study |
| Sunday, August 10 | | · | New PureYield™ Plasmid Miniprep System Helps Streamline Workflows |
| Wednesday, August 06 | | · | Vista Partners Sets $3.57 Price Target for VGX/Inovio |
| Monday, August 04 | | · | Expression Genetics Inc., Specializing in DNA/RNAi Delivery and Therapeutics, Completes $12M Series B Financing |
| Thursday, July 31 | | · | MMI raises funds for oncology programs |
| Tuesday, July 22 | | · | Roche to buy US-based Mirus Bio for 125 million dollars |
Older Articles
|
| |
